Regional Arterial Infusion Chemotherapy improves the Pathological Response rate for advanced gastric cancer with Short-term Neoadjuvant Chemotherapy

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wu, Zhen Feng ^a   Cao, Qin Hong ^a   Wu, Xiao Yu ^a   Chen, Che ^a   Xu, Zhe ^a   Li, Wei Su ^a   Yao, Xue Quan ^a   Liu, Fu Kun ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE EFFECTS; AGED; BLOOD; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; MORTALITY; NEOADJUVANT THERAPY; PROCEDURES; STOMACH NEOPLASMS; SURVIVAL RATE;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84949310218     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17516     Document Type: Article

References (32)

1. Crew, K. D., Neugut, A. I. Epidemiology of gastric cancer. World J Gastroenterol 12, 354-362 (2006).
2. Anderson, W. F. et al. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA 303, 1723-1728 (2010).
3. Waddell, T. et al. Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24 Suppl 6, vi57-63 (2013).
4. Cunningham, D. et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355, 11-20 (2006).
5. Ott, K. et al. Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study. Clin Cancer Res 14, 2012-2018 (2008).
6. Mori, S., Kishimoto, H., Tauchi, K., Higuchi, K. Histological complete response in advanced gastric cancer after 2 weeks of S-1 administration as neoadjuvant chemotherapy. Gastric Cancer 9, 136-139 (2006).
7. Watanabe, T. et al. Pathological complete response of locally advanced gastric cancer after four courses of neoadjuvant chemotherapy with paclitaxel plus cisplatin: report of a case. Surg Today 42, 983-987 (2012).
8. Yoshikawa, T. et al. Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer. Br J Surg 96, 1015-1022 (2009).
9. Yoshikawa, T. et al. A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study). Eur J Surg Oncol 36, 546-551 (2010).
10. Chen, L. et al. Correlation between expressions of ERCC1/TS mRNA and effects of gastric cancer to chemotherapy in the short term. Cancer Chemother Pharmacol 71, 921-928 (2013).
11. Zhang, C. W., Zou, S. C., Shi, D., Zhao, D. J. Clinical significance of preoperative regional intra-arterial infusion chemotherapy for advanced gastric cancer. World J Gastroenterol 10, 3070-3072 (2004).
12. Japanese Gastric Cancer, A. Japanese Classification of Gastric Carcinoma-2nd English Edition. Gastric Cancer 1, 10-24 (1998).
13. Mandard, A. M. et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73, 2680-2686 (1994).
14. Beddy, D. et al. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy. Ann Surg Oncol 15, 3471-3477 (2008).
15. Clavien, P. A. et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250, 187-196 (2009).
16. Yoshikawa, T. et al. Induction of a pathological complete response by four courses of neoadjuvant chemotherapy for gastric cancer: early results of the randomized phase II COMPASS trial. Ann Surg Oncol 21, 213-219 (2014).
17. Zu, H., Wang, H., Li, C., Xue, Y. Clinicopathologic characteristics and prognostic value of various histological types in advanced gastric cancer. Int J Clin Exp Pathol 7, 5692-5700 (2014).
18. Sun, L. B. et al. Comparison between better and poorly differentiated locally advanced gastric cancer in preoperative chemotherapy: a retrospective, comparative study at a single tertiary care institute. World J Surg Oncol 12, 280 (2014).
19. Ajani, J. A. et al. Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol 23, 1237-1244 (2005).
20. Chang, Y. C. et al. Clinicopathologic features and long-term results of alpha-fetoprotein-producing gastric cancer. Am J Gastroenterol 85, 1480-1485 (1990).
21. Chun, H., Kwon, S. J. Clinicopathological characteristics of alpha-fetoprotein-producing gastric cancer. J Gastric Cancer 11, 23-30 (2011).
22. Liu, X. et al. Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases. J Surg Oncol 102, 249-255 (2010).
23. Chang, Y. C. et al. alpha Fetoprotein producing early gastric cancer with liver metastasis: report of three cases. Gut 32, 542-545 (1991).
24. Kono, K. et al. Clinicopathologic features of gastric cancers producing alpha-fetoprotein. Dig Surg 19, 359-365 (2002).
25. Koide, N. et al. Alpha-fetoprotein-producing gastric cancer: histochemical analysis of cell proliferation, apoptosis, and angiogenesis. Am J Gastroenterol 94, 1658-1663 (1999).
26. Tokairin, Y. et al. [Pharmacokinetics of "subselective" arterial infusion chemotherapy]. Gan To Kagaku Ryoho 28, 1795-1798 (2001).
27. Ensminger, W. D. Intrahepatic arterial infusion of chemotherapy: pharmacologic principles. Semin Oncol 29, 119-125 (2002).
28. Uzgare, R. P., Sheets, T. P., Johnston, D. S. Evaluation of melphalan, oxaliplatin, and paclitaxel in colon, liver, and gastric cancer cell lines in a short-term exposure model of chemosaturation therapy by percutaneous hepatic perfusion. Anticancer Res 33, 1989-2000 (2013).
29. Becker, K. et al. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 98, 1521-1530 (2003).
30. Becker, K. et al. Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases. Ann Surg 253, 934-939 (2011).
31. Kemeny, N., Fata, F. Hepatic-arterial chemotherapy. Lancet Oncol 2, 418-428 (2001).
32. Kosaka, T. et al. [Evaluation of intra-arterial infusion chemotherapy for advanced gastric cancer]. Gan To Kagaku Ryoho 25, 1288-1291 (1998).